These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38155481)

  • 1. Is serum-derived exosomal hTERT transcript a marker of oncogenic activity in primary brain tumors? An exploratory study.
    Uziel O; Kanner AA; Beery E; Lev S; Lahav M; Horn-Fichman S; Nof SH; Laviv Y; Yust-Katz S; Amiel A; Shkara RA; Siddeeq M; Levy-Barda A; Raanani P; Sela Y; Cohen Z; Siegal T
    Cancer Med; 2024 Jan; 13(1):e6784. PubMed ID: 38155481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between telomerase activity, hTERT and telomere length for intracranial tumours.
    Maes L; Van Neste L; Van Damme K; Kalala JP; De Ridder L; Bekaert S; Cornelissen M
    Oncol Rep; 2007 Dec; 18(6):1571-6. PubMed ID: 17982646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo.
    Cabuy E; de Ridder L
    Virchows Arch; 2001 Aug; 439(2):176-84. PubMed ID: 11561758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression.
    Simon M; Park TW; Leuenroth S; Hans VH; Löning T; Schramm J
    J Neurosurg; 2000 May; 92(5):832-40. PubMed ID: 10794298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.
    Nguyen HN; Lie A; Li T; Chowdhury R; Liu F; Ozer B; Wei B; Green RM; Ellingson BM; Wang HJ; Elashoff R; Liau LM; Yong WH; Nghiemphu PL; Cloughesy T; Lai A
    Neuro Oncol; 2017 Mar; 19(3):394-404. PubMed ID: 27571882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of blood-derived exosomal hTERT mRNA secretion in cancer patients: a potential pan-cancer marker.
    Goldvaser H; Gutkin A; Beery E; Edel Y; Nordenberg J; Wolach O; Rabizadeh E; Uziel O; Lahav M
    Br J Cancer; 2017 Jul; 117(3):353-357. PubMed ID: 28641311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461.
    Li G; Shen J; Cao J; Zhou G; Lei T; Sun Y; Gao H; Ding Y; Xu W; Zhan Z; Chen Y; Huang H
    J Exp Clin Cancer Res; 2018 Apr; 37(1):78. PubMed ID: 29631594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the potential of circulating hTERT levels in glioma: can plasma levels serve as an independent prognostic marker?
    Gandhi P; Khare R; Garg N
    J Neurooncol; 2017 Nov; 135(2):255-261. PubMed ID: 28756592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between the expression of hTERT and α and β splice variants in human brain tumors.
    Khajehgoodari R; Khorvash F; Kheirollahi M; Mirsafaie M; Salehi M
    Adv Clin Exp Med; 2019 Apr; 28(4):507-513. PubMed ID: 31044567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity, TERT expression, hTERT promoter alterations, and alternative lengthening of the telomeres (ALT) in meningiomas - a systematic review.
    Stögbauer L; Stummer W; Senner V; Brokinkel B
    Neurosurg Rev; 2020 Jun; 43(3):903-910. PubMed ID: 30788677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas.
    Dorris K; Sobo M; Onar-Thomas A; Panditharatna E; Stevenson CB; Gardner SL; Dewire MD; Pierson CR; Olshefski R; Rempel SA; Goldman S; Miles L; Fouladi M; Drissi R
    J Neurooncol; 2014 Mar; 117(1):67-76. PubMed ID: 24477622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of astrocytomas and meningiomas: an evaluation in vitro.
    Maes L; Kalala JP; Cornelissen M; de Ridder L
    Cell Prolif; 2007 Feb; 40(1):14-23. PubMed ID: 17227292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of hTERT expression to maspin and bFGF expression and their significance in glioma].
    Wang DL; Wang YF; Shi GS; Huang H
    Ai Zheng; 2007 Jun; 26(6):601-6. PubMed ID: 17562265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells.
    Pallini R; Pierconti F; Falchetti ML; D'Arcangelo D; Fernandez E; Maira G; D'Ambrosio E; Larocca LM
    J Neurosurg; 2001 Jun; 94(6):961-71. PubMed ID: 11409526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Levels of APRIL Increase in Patients with Glioma, Meningioma and Schwannoma.
    Fouladseresht H; Ziaee SM; Erfani N; Doroudchi M
    Asian Pac J Cancer Prev; 2019 Mar; 20(3):751-756. PubMed ID: 30909681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker.
    Harada K; Kurisu K; Tahara H; Tahara E; Ide T; Tahara E
    J Neurosurg; 2000 Oct; 93(4):618-25. PubMed ID: 11014540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
    Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
    Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive overview of extracellular vesicle proteomics in meningioma: future strategy.
    Rana R; Sharma S; Ganguly NK
    Mol Biol Rep; 2021 Dec; 48(12):8061-8074. PubMed ID: 34687392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningiomas, dicentric chromosomes, gliomas, and telomerase activity.
    Carroll T; Maltby E; Brock I; Royds J; Timperley W; Jellinek D
    J Pathol; 1999 Aug; 188(4):395-9. PubMed ID: 10440750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase activity and hTERT protein expression in meningiomas: an analysis in vivo versus in vitro.
    Maes L; Kalala JP; Cornelissen R; de Ridder L
    Anticancer Res; 2006; 26(3B):2295-300. PubMed ID: 16821605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.